Virtual Webinar Programme

Our weekly webinar series has been designed to ensure you stay connected with what’s happening in the cancer research landscape. Learn and discover the latest breakthroughs, ongoing developments and research updates. Scroll down to find out more about each webinar and register your place for free. Make sure you check back regularly as we release more details about upcoming webinars!


Already registered for an event? Please download the Microsoft Teams Live Events how-to guide here.


Watch past webinars on demand

Employing big data to solve big problems: Challenges and opportunities to close the cancer equity divide

Date: Tuesday 29 September 2020
Time: 13:30 -14:30 (BST)
Chairs: Dr Allison Landman, The Lancet Oncology, UK and Professor Richard Sullivan, King’s College London, UK
Speakers: Professor Mark Lawler, Dr Matti Aapro, Jacqui Gath

This session will consider how we use data intelligence to gain an improved understanding of disease development, cancer treatment and long term care, and also how detailed cancer intelligence can help shape cancer policies at regional, national and global levels. Speakers will address concerns about whether applications of big data research might inadvertently exacerbate cancer inequalities, rather than reducing existing health disparities. For example, the under-representation of minority and vulnerable populations in big datasets may lead to biased conclusions that threaten equitable progress in cancer research and care, so this important topic will also be considered and addressed.

Register for free More info

The cost and burden of cancer treatment – what can we learn?

Date: Thursday 1 October 2020
Time: 13:30 -14:30 (BST)
Chair: Professor Matt Seymour, NIHR Clinical Research Networks, UK
Speakers: Professor Mark Sculpher, Professor Peter Clark, Dr Ajay Aggarwal, Dr Adrienne Morgan

This session will consider the cost of cancer treatment to the NHS and explore ways in which better ‘value for money’ could be provided, as well as improve benefits for patients. Panellists will discuss important topics such as the perceived and actual value of treatment and care for patients, when and how collaboration between academia and industry can really work, and the role of interventional pharmacoeconomics to ensure better value and to alleviate the pressures on the healthcare system. Panellists will also consider any lessons learnt in the context of the Covid-19 pandemic and the current and future economic challenges.

Register for free More info

Dying from cancer: Prognostication, public and professional attitudes, and problematic treatment

Date: Thursday 8 October 2020
Time: 13:30 -14:30 (BST)
Chair: Professor Joanne Reid, Queen’s University Belfast, UK
Speakers: Carolyn Canfield, Professor Paddy Stone, Professor Annmarie Nelson

This session will cover the sensitive areas around recognizing dying patients and negotiating appropriate treatment decisions. Panellists will discuss improved accuracy of prognostication through training and by introducing prognostic tools into clinical practice. They will explore public perceptions, the consequences of restricted communication about death and dying, its impact on discussing or stopping treatment, and planning for end of life care. Ways to support patients and clinicians in recognizing individual priorities as a framework for treatment decisions, and to reduce incidences of avoidable harm from inappropriate treatment will also be discussed.

Register for free More info

In conversation with…Christine Friedenreich 

Date: Tuesday 13 October 2020
Time: 16:00 -16:45 (BST)
Chair: Professor Anna Campbell MBE, Edinburgh Napier University, UK
Speaker: Dr Christine Friedenreich, University of Calgary, Canada

Join Christine as she explores the role of physical activity and exercise in the prevention and control of cancer. The discussion will consider current evidence and guidelines and reflect on the role of health care professionals, researchers, patients and carers as well as policy makers in influencing behaviours, reducing risk and improving survival and quality of life. Consideration will be given to the similarities and differences between the Canadian and UK systems, and reflect on unanswered key questions.

Register for free More info